Healthcare Analysts discuss what is new and on the horizon (relevant companies ANTX INSM MNKD SPRO) for treatment of the Non-Tuberculosis Mycobacteria Lung Disease on an Analyst/Industry conference call to be held on February 24.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX:
